Details for New Drug Application (NDA): 050533
✉ Email this page to a colleague
NDA 050533 describes VIBRA-TABS, which is a drug marketed by Pfizer and is included in one NDA. Additional details are available on the VIBRA-TABS profile page.
The generic ingredient in VIBRA-TABS is doxycycline hyclate. There are twenty-eight drug master file entries for this compound. Seventy-four suppliers are listed for this compound. Additional details are available on the doxycycline hyclate profile page.
The generic ingredient in VIBRA-TABS is doxycycline hyclate. There are twenty-eight drug master file entries for this compound. Seventy-four suppliers are listed for this compound. Additional details are available on the doxycycline hyclate profile page.
Summary for 050533
| Tradename: | VIBRA-TABS |
| Applicant: | Pfizer |
| Ingredient: | doxycycline hyclate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
